Healthcare Industry News:  AxioMed Spine 

Devices Personnel

 News Release - May 10, 2006

AxioMed Spine Corporation Announces the Appointment of Patrick McBrayer as President and CEO

GARFIELD HEIGHTS, Ohio--(HSMN NewsFeed)--May 10, 2006--AxioMed® Spine Corporation, a development stage medical company with innovative spinal implants to restore the native motion of the spine, announces the addition of Patrick A. McBrayer as President and Chief Executive Officer in February 2006. He joins AxioMed during the development of the Freedom(TM) Lumbar Disc (FLD) System, the next generation of total disc replacement and first implant system in the Company's pipeline. AxioMed's goal is to establish clinical and economic value of this pioneering technology through rigorous, well planned clinical studies in the United States and Europe.

Mr. McBrayer joins AxioMed from Xylos Corporation, a biomaterials company, where he served as Chairman and CEO. Prior to joining Xylos, Mr. McBrayer served as President and CEO of Exogen, Inc., a company focused on the non-invasive treatment of musculoskeletal injury and disease, which was acquired by Smith & Nephew, Inc. in 1999. Previously, Mr. McBrayer was President and CEO of Osteotech, Inc., a worldwide leader in tissue technology. In each of these companies he was responsible for a number of private placements and in the later two companies' public offerings. Prior to joining Osteotech, Mr. McBrayer held positions of increasing responsibility for Johnson & Johnson, Inc.

Jim Kuras, AxioMed's Co-founder and Chief Operating Officer stated, "The team is delighted to have Pat join us at this important stage of our development. He has a broad background in orthopedics including devices, biologics, biomaterials and non-invasive bone repair. One of his patents pioneered biologic repair of the spine thus he fits well with our company of inventors and thought leaders."

AxioMed is financed by a consortium of leading venture capital investors. Pete McNerney, Managing Partner at Thomas, McNerney & Partners, stated, "We selected Pat because he complements our strong management team at AxioMed. In addition to his product development and introduction accomplishments, he has experience in raising private funds and has taken two orthopedic companies public. We intend to build a significant spine company with this fine team."

Source: AxioMed Spine

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.